SolAeroMed Newsletter #11

SolAeroMed Shareholder Newsletter #11     January 21, 2015 Hello SAMi shareholders We write to provide an update on our evolving development at SolAeroMed (SAMi). Clinical Development:  We had a productive and busy end to 2014 which included the formal start of our Phase IIa ‘proof of concept’ clinical trial which started December 16th in Calgary’s Foothills

Read more

S1226 Phase IIa initiated

SolAeroMed submitted a Clinical Trial Application to Health Canada regulators and on Oct 23  obtained formal regualtory approval to proceed.  Work with colleagues at the Foothills Hospital under direction of Prof Richard Leigh, SolAeroMed management with support from JSS consultants, to have all required drugs and documents in place.  The official start date for this

Read more

top